Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.creator | Vilar, Lucio | - |
Autor(es): dc.creator | Abucham, Julio | - |
Autor(es): dc.creator | Albuquerque, José Luciano | - |
Autor(es): dc.creator | Araujo, Luiz Antônio | - |
Autor(es): dc.creator | Azevedo, Monalisa F. | - |
Autor(es): dc.creator | Boguszewski, Cesar Luiz | - |
Autor(es): dc.creator | Casulari, Luiz Augusto | - |
Autor(es): dc.creator | Cunha Neto, Malebranche B. C. | - |
Autor(es): dc.creator | Czepielewski, Mauro Antonio | - |
Autor(es): dc.creator | Duarte, Felipe H. G. | - |
Autor(es): dc.creator | Faria, Manuel dos S. | - |
Autor(es): dc.creator | Gadelha, Monica R. | - |
Autor(es): dc.creator | Garmes, Heraldo M. | - |
Autor(es): dc.creator | Glezer, Andrea | - |
Autor(es): dc.creator | Gurgel, Maria Helane | - |
Autor(es): dc.creator | Jallad, Raquel S. | - |
Autor(es): dc.creator | Martins, Manoel | - |
Autor(es): dc.creator | Miranda, Paulo A. C. | - |
Autor(es): dc.creator | Montenegro, Renan M. | - |
Autor(es): dc.creator | Musolino, Nina R. C. | - |
Autor(es): dc.creator | Naves, Luciana Ansaneli | - |
Autor(es): dc.creator | Ribeiro-Oliveira Júnior, Antônio | - |
Autor(es): dc.creator | Silva, Cíntia M. S. | - |
Autor(es): dc.creator | Viecceli, Camila | - |
Autor(es): dc.creator | Bronstein, Marcello D. | - |
Data de aceite: dc.date.accessioned | 2021-10-14T17:49:20Z | - |
Data de disponibilização: dc.date.available | 2021-10-14T17:49:20Z | - |
Data de envio: dc.date.issued | 2019-01-02 | - |
Data de envio: dc.date.issued | 2019-01-02 | - |
Data de envio: dc.date.issued | 2018 | - |
Fonte completa do material: dc.identifier | http://repositorio.unb.br/handle/10482/33729 | - |
Fonte completa do material: dc.identifier | http://dx.doi.org/10.20945/2359-3997000000032 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/capes/617044 | - |
Descrição: dc.description | Prolactinomas are the most common pituitary adenomas (approximately 40% of cases), and they represent an important cause of hypogonadism and infertility in both sexes. The magnitude of prolactin (PRL) elevation can be useful in determining the etiology of hyperprolactinemia. Indeed, PRL levels > 250 ng/mL are highly suggestive of the presence of a prolactinoma. In contrast, most patients with stalk dysfunction, drug-induced hyperprolactinemia or systemic diseases present with PRL levels < 100 ng/mL. However, exceptions to these rules are not rare. On the other hand, among patients with macroprolactinomas (MACs), artificially low PRL levels may result from the so-called “hook effect”. Patients harboring cystic MACs may also present with a mild PRL elevation. The screening for macroprolactin is mostly indicated for asymptomatic patients and those with apparent idiopathic hyperprolactinemia. Dopamine agonists (DAs) are the treatment of choice for prolactinomas, particularly cabergoline, which is more effective and better tolerated than bromocriptine. After 2 years of successful treatment, DA withdrawal should be considered in all cases of microprolactinomas and in selected cases of MACs. In this publication, the goal of the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism (SBEM) is to provide a review of the diagnosis and treatment of hyperprolactinemia and prolactinomas, emphasizing controversial issues regarding these topics. This review is based on data published in the literature and the authors' experience. | - |
Formato: dc.format | application/pdf | - |
Idioma: dc.language | en | - |
Publicador: dc.publisher | Sociedade Brasileira de Endocrinologia e Metabologia | - |
Direitos: dc.rights | Acesso Aberto | - |
Direitos: dc.rights | Archives of Endocrinology and Metabolism - (CC BY) This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Fonte: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972018000200236&lng=en&nrm=iso. Acesso em: 29 jan. 2019. | - |
Palavras-chave: dc.subject | Hiperprolactinemia | - |
Palavras-chave: dc.subject | Prolactinoma | - |
Palavras-chave: dc.subject | Pseudoprolactinomas | - |
Palavras-chave: dc.subject | Macroprolactina | - |
Palavras-chave: dc.subject | Dopamina | - |
Palavras-chave: dc.subject | Cirurgia | - |
Palavras-chave: dc.subject | Temozolomida | - |
Título: dc.title | Controversial issues in the management of hyperprolactinemia and prolactinomas : an overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism | - |
Tipo de arquivo: dc.type | livro digital | - |
Aparece nas coleções: | Repositório Institucional – UNB |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: